Percutaneous Coronary Intervention

15 · 20 / page

Ask MedXY AI

Latest news

Tag

Cardiologychronic total occlusionPercutaneous Coronary Intervention

ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina

By MedXY|Jul 14, 2026

The ORBITA-CTO multicenter, randomized, placebo-controlled trial demonstrates that PCI significantly improves angina symptoms and quality of life in patients with single-vessel CTO without bystander disease, compared to placebo.

Ultra-Thin Sirolimus-Eluting Stents Show Noninferiority to Everolimus-Eluting Stents in Diabetic Multivessel CAD: Insights from TUXEDO-2 Trial

Percutaneous Coronary Intervention

Latest news

ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina

Ultra-Thin Sirolimus-Eluting Stents Show Noninferiority to Everolimus-Eluting Stents in Diabetic Multivessel CAD: Insights from TUXEDO-2 Trial

Can a Sirolimus-Eluting Balloon Reduce Stent Use in De Novo Coronary Disease? New Randomized Evidence from SELUTION DeNovo

Optimizing Antiplatelet Strategies in Complex PCI: Insights from the TAILORED-CHIP Trial and Evolving Evidence for Temporal Modulation

Focal vs. Diffuse Coronary Artery Disease: How Disease Pattern Influences PCI’s Placebo-Controlled Symptom Relief in ORBITA-2

Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions: EUROCTO and DECISION-CTO Meta-Analysis

Targeting the Rock: Why Contralateral Calcification Defines the Success of Rotational Atherectomy in Calcified Nodules

The 30-Day Ischemic Penalty: Why Early Aspirin Withdrawal in ACS Requires Caution

Advances in Optical Coherence Tomography-Guided Coronary Stenting: Insights from the ILUMIEN IV Trial and Related Studies

NOAC Monotherapy After Drug‑Eluting Stent: Safer and at Least as Effective as NOAC Plus Clopidogrel in AF Patients ≥1 Year After PCI

Immediate vs Deferred PCI for Nonculprit Lesions in STEMI: Insights from the iMODERN Trial

Exploring the Impact of Reduced Left Ventricular Function on Outcomes After PCI in Chronic Kidney Disease Patients

Long-Term Comparative Outcomes of FFR vs IVUS-Guided PCI in Intermediate Coronary Stenosis: Insights from the FLAVOUR Trial Extended Follow-Up

Decade-Long Insights into Deferred Versus Immediate Stenting in STEMI Patients: DANAMI-3-DEFER Trial Findings

Delayed Remote Ischemic Preconditioning Reduces Contrast-Associated Acute Kidney Injury After Coronary Angiography and PCI: Insights from a Randomized Trial